We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONMD icon
276
OneMedNet
ONMD
$41M
$1.07M 0.03%
102,392
+13,395
+15% +$140K
EPHY
277
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$1.06M 0.03%
106,329
+86,045
+424% +$859K
GBBK
278
DELISTED
Global Blockchain Acquisition Corp. Common Stock
GBBK
$1M 0.03%
99,381
+24,381
+33% +$243K
AHRN
279
DELISTED
Ahren Acquisition Corp
AHRN
$988K 0.03%
96,579
+5,570
+6% +$56.6K
NVAC
280
DELISTED
NorthView Acquisition Corporation Common Stock
NVAC
$970K 0.03%
95,713
-23,360
-20% -$234K
ARIZ
281
DELISTED
Arisz Acquisition Corp. Common Stock
ARIZ
$961K 0.02%
95,101
+1
+0% +$10
MEKA
282
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$952K 0.02%
+95,367
New +$946K
RENE
283
DELISTED
Cartesian Growth Corp II
RENE
$937K 0.02%
+91,393
New +$927K
PLTNU
284
DELISTED
Plutonian Acquisition Corp. Unit
PLTNU
$933K 0.02%
+92,700
New +$934K
YTPG
285
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$932K 0.02%
94,845
-5,255
-5% -$51.7K
AVEO
286
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$928K 0.02%
+62,066
New +$859K
RFAC
287
DELISTED
RF Acquisition Corp. Class A Common Stock
RFAC
$918K 0.02%
90,812
+25,574
+39% +$255K
BSAQ
288
DELISTED
Black Spade Acquisition Co
BSAQ
$850K 0.02%
84,950
+49,648
+141% +$493K
LIBY
289
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
$835K 0.02%
81,806
+17,538
+27% +$178K
KAIR
290
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$812K 0.02%
80,567
-2,066,267
-96% -$20.7M
VBOC
291
DELISTED
Viscogliosi Brothers Acquisition Corp Common Stock
VBOC
$811K 0.02%
80,193
-18,522
-19% -$185K
SCAQ
292
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
$807K 0.02%
80,570
-6,747
-8% -$67K
DGNU
293
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$782K 0.02%
79,282
-20,818
-21% -$205K
DSAQ
294
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$760K 0.02%
73,893
-2,441
-3% -$24.9K
GLST
295
DELISTED
Global Star Acquisition, Inc. Class A Common Stock
GLST
$749K 0.02%
+73,963
New +$744K
MLAI
296
DELISTED
McLaren Technology Acquisition Corp. Class A Common Stock
MLAI
$723K 0.02%
70,853
-16,106
-19% -$163K
FRONU
297
DELISTED
Frontier Acquisition Corp. Units
FRONU
$708K 0.02%
70,198
+32,132
+84% +$321K
NOVV
298
DELISTED
Nova Vision Acquisition Corp. Ordinary share
NOVV
$694K 0.02%
66,454
-26,124
-28% -$269K
CITE
299
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$679K 0.02%
65,819
+53,477
+433% +$547K
BPAC
300
DELISTED
Bullpen Parlay Acquisition Company Class A Ordinary Share
BPAC
$678K 0.02%
66,231
+27,783
+72% +$282K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.